Inspection Record

Y.S.P. Industries (M) Sdn. Bhd. — Health Canada Inspection Findings

Health CanadaInspected 2023-04-06 12 findingsContamination controlOther quality systemEquipment and facilityLabeling and packagingLaboratory and QC controlsComputer system validationDeviation, CAPA, and investigationStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination. The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

2Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

3Equipment and facility

The maintenance of the premises was inadequate.

4Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

5Labeling and packaging

The implementation of minimum health and hygiene requirements for personnel was inadequate for ensuring the clean and sanitary fabrication, packaging, and/or labelling of drugs.

6Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate.

7Laboratory and QC controls

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate. The quality control department did not undertake all of the required activities.

8Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

9Equipment and facility

The maintenance of records was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

10Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

11Laboratory and QC controls

The quality control department did not appropriately approve, assess, and/or document the reprocessing and/or reworking of a lot and/or batch.

12Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-04-06. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Y.S.P. Industries (M) Sdn. Bhd. company profile — full history Health Canada documents, 2023 Go to Findings search